Skip to main content
Rainmed Medical Limited logo

Rainmed Medical Limited — Investor Relations & Filings

Ticker · 2297 HKEX Manufacturing
Open in API
Filings indexed 135 across all filing types
Latest filing 2025-09-28 Regulatory Filings
Country HK Hong Kong
Listing HKEX 2297

About Rainmed Medical Limited

http://www.rainmed.com

Rainmed Medical Group, founded in 2014, is a high-tech enterprise specializing in the research, development, manufacturing, and commercialization of advanced medical instruments for vascular interventional procedures. The company is committed to becoming a global leader in vascular interventional surgical robotics. Its core product portfolio centers on robotic digital functional diagnosis modules, including the coronary angiography-derived fractional flow reserve (caFFR) system and the coronary angiography-derived microvascular resistance index (caIMR) system. These diagnostic tools form the foundation for the development of the FlashBot Vascular Interventional Surgical Robot, which aims to provide a one-stop procedural solution for precision medicine in cardiovascular care. Rainmed maintains a global R&D network, collaborates with top medical centers, and focuses on advancing its patented technologies.

Recent filings

Filing Released Lang Actions
CLARIFICATION ANNOUNCEMENT IN RELATION TO THE INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2025
Regulatory Filings Classification · 1% confidence The document is a short, corrective announcement clarifying inadvertent errors in the Company’s previously issued interim results announcement for the six months ended June 30, 2025. It does not include the full interim report itself (IR) nor is it the initial release of results (ER); rather, it is a follow-up regulatory notification to correct disclosed figures. Therefore, it fits the fallback category for miscellaneous regulatory filings.
2025-09-28 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 August 2025
Share Issue/Capital Change Classification · 1% confidence The document is an HKEX Form FF301 “Monthly Return for Equity Issuer and Hong Kong Depositary Receipts” showing detailed movements in authorised share capital, issued shares, share options, and other share capital changes for the month ended 31 August 2025. It is not an annual or interim report, earnings release, management discussion, or AGM material. Instead, it is a periodic regulatory submission primarily concerned with capital structure changes—new issuances, share option exercises, and related matters. This corresponds to the “Share Issue/Capital Change” category (SHA).
2025-09-02 English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2025
Interim / Quarterly Report Classification · 1% confidence The document is an 'Interim Results Announcement' for Rainmed Medical Limited for the six months ended June 30, 2025. It contains comprehensive unaudited interim condensed consolidated financial statements, including the income statement, balance sheet, statement of comprehensive income, and detailed notes to the financial information. As it provides substantive financial data for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report. H2 2025
2025-08-28 English
DATE OF BOARD MEETING
Regulatory Filings Classification · 1% confidence The document is a brief announcement by Rainmed Medical Limited stating the date of a board meeting to consider and approve interim results and a potential interim dividend. It is not the report itself, nor a change in board membership, nor a proxy solicitation or dividend notice with amounts. It simply notifies investors of an upcoming board meeting – a general regulatory announcement that does not fit a more specific category. Therefore, it falls under the fallback “Regulatory Filings” (RNS).
2025-08-18 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 July 2025
Regulatory Filings Classification · 1% confidence The document is a statutory monthly return (Form FF301) submitted to the Hong Kong Stock Exchange under Chapter 19B of the Listing Rules, detailing movements in authorized/registered share capital, issued shares, share options, etc. It is not an earnings release, annual or interim report, nor an investor presentation or proxy statement. It is a required regulatory filing to HKEX. Therefore it falls under the fallback category for general regulatory submissions: Regulatory Filings (RNS).
2025-08-04 English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Board/Management Information Classification · 1% confidence The document provides a detailed list of the company’s board members, their roles (executive, non-executive, independent), and committee memberships. It is an announcement of the company’s board composition and management structure rather than a financial report, transcript, or other category. This aligns with the "Board/Management Information" category.
2025-07-15 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.